Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.71%46.13B | 17.91%196.77B | 17.48%46.93B | 1.75%166.88B | 0.12%42.35B | 3.71%42.18B | 3.92%42.4B | -0.73%39.95B | 10.02%164.02B | 3.45%42.3B |
| Cost of revenue | -0.25%36.23B | 21.76%162.54B | 14.34%36.32B | 3.45%133.49B | -2.30%34.33B | 5.04%34.05B | 5.90%33.34B | 5.88%31.76B | 12.98%129.04B | 7.50%35.14B |
| Gross profit | -6.69%9.91B | 2.50%34.23B | 29.63%10.62B | -4.53%33.4B | 11.97%8.02B | -1.51%8.13B | -2.78%9.06B | -20.08%8.19B | 0.34%34.98B | -12.68%7.16B |
| Operating expense | 4.61%6.28B | 7.90%23.97B | 11.01%6.01B | 4.07%22.22B | 7.61%5.77B | 5.00%5.77B | -1.46%5.27B | 5.13%5.41B | 11.49%21.35B | 10.93%5.36B |
| Operating profit | -21.42%3.62B | -8.24%10.26B | 65.87%4.61B | -18.00%11.18B | 24.92%2.25B | -14.53%2.35B | -4.55%3.8B | -45.53%2.78B | -13.25%13.63B | -46.53%1.8B |
| Net non-operating interest income (expenses) | -134.48%-68M | -26.59%-338M | 70.71%-29M | 29.55%-267M | 58.72%-45M | 48.94%-48M | 29.25%-75M | -41.43%-99M | -59.24%-379M | -98.18%-109M |
| Non-operating interest income | -72.12%58M | 44.53%581M | 342.55%208M | 262.16%402M | 226.53%160M | 233.33%130M | 364.29%65M | 422.22%47M | 382.61%111M | 716.67%49M |
| Non-operating interest expense | -46.84%126M | 37.37%919M | 62.33%237M | 36.53%669M | 29.75%205M | 33.83%178M | 16.67%140M | 84.81%146M | 87.74%490M | 159.02%158M |
| Net investment income | 193.97%779M | -19.75%1.11B | -222.45%-829M | -6.45%1.38B | -131.14%-52M | 127.63%519M | 1,265.00%233M | -38.29%677M | 23.80%1.47B | 116.88%167M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 1,433.84%3.04B | 524.43%1.1B | -88.07%198M | 0 | -98.59%21M | -94.12%1M | 14.29%176M | 1,044.83%1.66B | 0 |
| Income from associates and other participating interests | -20.78%263M | 678.43%794M | 709.76%332M | 108.56%102M | 125.53%60M | 106.47%49M | 78.48%-48M | 78.26%41M | -1,069.11%-1.19B | -92.62%-235M |
| Special income (charges) | -64.16%500M | 42.20%-489M | 69,650.00%1.4B | -23.68%-846M | -47.41%-768M | -308.33%-25M | 57.36%-55M | 104.35%2M | -54.05%-684M | -313.49%-521M |
| Less:Other special charges | 62.32%-526M | -324.80%-1.42B | -69,700.00%-1.4B | 146.30%633M | 484.54%567M | 225.00%15M | -57.94%53M | -104.35%-2M | -23.96%257M | 56.45%97M |
| Less:Write off | 2,500.00%26M | 797.65%1.91B | --1M | -50.12%213M | -52.59%201M | --10M | -33.33%2M | --0 | 302.83%427M | 562.50%424M |
| Other non-operating income (expenses) | -157.89%-98M | -14.41%-381M | 11.63%-38M | -2.15%-333M | 107.69%5M | -46.94%-144M | -15.27%-151M | -34.38%-43M | -76.22%-326M | -54.76%-65M |
| Income before tax | -23.60%5B | 22.60%13.99B | 85.08%6.54B | -19.54%11.41B | 39.73%1.45B | -22.70%2.73B | 9.18%3.7B | -43.25%3.53B | -13.03%14.18B | -66.82%1.04B |
| Income tax | -37.12%1.31B | 10.16%4.39B | 99.71%2.09B | 26.04%3.99B | 158.97%937M | -41.78%836M | -14.77%1.17B | -46.27%1.04B | -38.08%3.16B | -263.65%-1.59B |
| Net income | -17.29%3.68B | 29.29%9.59B | 79.02%4.45B | -32.65%7.42B | -80.55%511M | -9.56%1.89B | 25.53%2.53B | -41.90%2.49B | -1.59%11.02B | 21.96%2.63B |
| Net income continuous operations | -17.27%3.69B | 29.29%9.59B | 78.95%4.45B | -32.64%7.42B | -80.50%512M | -9.60%1.89B | 25.53%2.53B | -41.89%2.49B | -1.60%11.02B | 21.91%2.63B |
| Noncontrolling interests | 60.17%386M | -29.87%573M | 42.60%241M | -33.79%817M | 76.24%356M | -74.17%86M | -6.36%206M | -64.72%169M | -35.53%1.23B | -59.36%202M |
| Net income attributable to the company | -21.74%3.3B | 36.61%9.02B | 81.75%4.21B | -32.49%6.6B | -93.61%155M | 2.61%1.81B | 29.50%2.32B | -39.03%2.32B | 5.40%9.78B | 46.29%2.42B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -21.74%3.3B | 36.61%9.02B | 81.75%4.21B | -32.49%6.6B | -93.61%155M | 2.61%1.81B | 29.50%2.32B | -39.03%2.32B | 5.40%9.78B | 46.29%2.42B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -17.25%41.914 | 37.76%109.348 | 81.68%50.65 | -32.49%79.376 | -93.59%1.868 | 2.57%21.716 | 29.54%27.914 | -39.02%27.878 | 5.41%117.578 | 46.30%29.142 |
| Diluted earnings per share | -17.25%41.914 | 37.76%109.348 | 81.68%50.65 | -32.49%79.376 | -93.61%1.8634 | 2.58%21.716 | 29.54%27.914 | -39.02%27.878 | 5.41%117.578 | 46.29%29.1405 |
| Dividend per share | 0 | 32.54%44.8 | 0 | -4.79%33.8 | -22.73%17 | 0 | 24.44%16.8 | 0 | 5.97%35.5 | 10.00%22 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |